Neurological Surgery 脳神経外科52巻4号

2024年07月発行

特集 髄膜腫の現在—最新の知識を活かした最善の治療のために Ⅴ 髄膜腫に対する集学的治療

髄膜腫に対する放射線治療の位置付け

著者： 川端信司¹ 柏木秀基¹ 野々口直助¹ 古瀬元雅¹ 髙見俊宏¹ 宮武伸一² 鰐渕昌彦¹

所属機関： ¹大阪医科薬科大学医学部脳神経外科学 ²大阪医科薬科大学関西BNCT共同医療センター

ページ範囲：P.782 - P.793

Point
・髄膜腫の再発リスクに関する層別化が進められ，髄膜腫においても分子診断が重要な役割を果たすようになってきた．
・放射線治療の役割は層別化に応じてより明確になっていくが，髄膜腫における放射線治療の臨床的な位置付けは未だ不明確である．
・放射線照射の標的領域の設定は治療成績を左右し得るが，PET画像などの腫瘍特性を反映した照射計画が試みられている．
・ホウ素中性子捕捉療法は生物学的に細胞レベルで治療ができることから，髄膜腫においても効果が期待されている．

参考文献

1）Simpson D：The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20：22-39, 1957

2）Wara WM, et al：Radiation therapy of meningiomas. Am J Roentgenol Radium Ther Nucl Med 123：453-458, 1975

3）Carella RJ, et al：Role of radiation therapy in the management of meningioma. Neurosurgery 10：332-339, 1982

4）Petty AM, et al：Radiation therapy for incompletely resected meningiomas. J Neurosurg 62：502-507, 1985

5）King DL, et al：Radiotherapy in the management of meningiomas. Acta Radiol Ther Phys Biol 5：26-33, 1966

6）Harrison G, et al：Quantitative tumor volumetric responses after Gamma Knife radiosurgery for meningiomas. J Neurosurg 124：146-154, 2016

7）Rogers CL, et al：Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539. Neuro Oncol 18：565-574, 2016

8）Gousias K, et al：The Simpson grading revisited：aggressive surgery and its place in modern meningioma management. J Neurosurg 125：551-560, 2016

9）Przybylowski CJ, et al：Prognostic value of the Simpson grading scale in modern meningioma surgery：Barrow Neurological Institute experience. J Neurosurg 135：515-523, 2021

10）Oya S, et al：Significance of Simpson grading system in modern meningioma surgery：integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade Ⅰ meningiomas. J Neurosurg 117：121-128, 2012

11）Sughrue ME, et al：The relevance of Simpson Grade Ⅰ and Ⅱ resection in modern neurosurgical treatment of World Health Organization Grade Ⅰ meningiomas. J Neurosurg 113：1029-1035, 2010

12）Schwartz TH, McDermott MW：The Simpson grade：abandon the scale but preserve the message. J Neurosurg 135：488-495, 2021

13）Hutzelmann A, et al：Dural invasion of meningiomas adjacent to the tumor margin on Gd-DTPA-enhanced MR images：histopathologic correlation. Eur Radiol 8：746-748, 1998

14）Borovich B, et al：Recurrence of intracranial meningiomas：the role played by regional multicentricity. J Neurosurg 64：58-63, 1986

15）Qi ST, et al：A radiopathological classification of dural tail sign of meningiomas. J Neurosurg 117：645-653, 2012

16）Mathiesen T, et al：Meningiomas engaging major venous sinuses. World Neurosurg 81：116-124, 2014

17）Eichberg DG, et al：Parasagittal and parafalcine meningiomas：integral strategy for optimizing safety and retrospective review of a single surgeon series. Br J Neurosurg 34：559-564, 2020

18）Raza SM, et al：Perioperative and long-term outcomes from the management of parasagittal meningiomas invading the superior sagittal sinus. Neurosurgery 67：885-893, 2010

19）Jääskeläinen J：Seemingly complete removal of histologically benign intracranial meningioma：late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 26：461-469, 1986

20）Chen WC, et al：Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy. J Neurosurg 130：443-450, 2018

21）Zhao P, et al：Prognostic factors for patients with atypical or malignant meningiomas treated at a single center. Neurosurg Rev 38：101-107, 2015

22）Gabeau-Lacet D, et al：Bone involvement predicts poor outcome in atypical meningioma. J Neurosurg 111：464-471, 2009

23）Goyal N, et al：Does bony hyperostosis in intracranial meningioma signify tumor invasion? A radio-pathologic study. Neurol India 60：50-54, 2012

24）Jin L, et al：Type of bony involvement predicts genomic subgroup in sphenoid wing meningiomas. J Neurooncol 154：237-246, 2021

25）Brokinkel B, et al：Brain invasion in meningiomas-clinical considerations and impact of neuropathological evaluation：a systematic review. Neuro Oncol 19：1298-1307, 2017

26）Pizem J, et al：Brain invasion assessability in meningiomas is related to meningioma size and grade, and can be improved by extensive sampling of the surgically removed meningioma specimen. Clin Neuropathol 33：354-363, 2014

27）Timme M, et al：Brain invasion in meningiomas：does surgical sampling impact specimen characteristics and histology? Neurosurg Rev 43：793-800, 2020

28）Nakasu S, et al：Microscopic anatomy of the brain-meningioma interface. Brain Tumor Pathol 22：53-57, 2005

29）Baumgarten P, et al：Brain invasion in otherwise benign meningiomas does not predict tumor recurrence. Acta Neuropathol 132：479-481, 2016

30）Nakasu S, et al：Prognostic significance of brain invasion in meningiomas：systematic review and meta-analysis. Brain Tumor Pathol 38：81-95, 2021

31）Perry A, et al：Meningioma grading：an analysis of histologic parameters. Am J Surg Pathol 21：1455-1465, 1997

32）Susko MS, et al：Patterns of failure after adjuvant radiation for meningioma, radiologic assessment to inform target delineation and treatment planning. Int J Radiat Oncol Biol Phys 108：e732-e733, 2020　doi.org/10.1016/j.ijrobp.2020.07.129

33）Schuring-Pereira M, et al：Atypical meningioma：patterns of postradiotherapy recurrences. Br J Neurosurg 35：591-596, 2021

34）Susko MS, et al：Letter：Patterns of intermediate- and high-risk meningioma recurrence after treatment with postoperative external beam radiotherapy. Neurosurgery 89：E99-E101, 2021　doi:10.1093/neuros/nyab143

35）Rogers L, et al：Meningiomas：knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg 122：4-23, 2015

36）Maclean J, et al：Controversies in radiotherapy for meningioma. Clin Oncol（R Coll Radiol）26：51-64, 2014

37）Hall JT, et al：The effect of radiation on meningioma volume change. World Neurosurg 153：e141-e146, 2021　doi:10.1016/j.wneu.2021.06.080

38）Fega KR, et al：Analysis of MRI volumetric changes after hypofractionated stereotactic radiation therapy for benign intracranial neoplasms. Adv Radiat Oncol 4：43-49, 2019

39）de Melo LP, et al：Radiotherapy for the treatment of optic nerve sheath meningioma：a systematic review and meta-analysis. Radiother Oncol 165：135-141, 2021

40）Leroy HA, et al：Radiosurgery and fractionated radiotherapy for cavernous sinus meningioma：a systematic review and meta-analysis. Acta Neurochir（Wien）160：2367-2378, 2018

41）Rogers CL, et al：Low-risk meningioma：Initial outcomes from NRG Oncology/RTOG 0539. Neuro Oncol 25：137-145, 2023

42）Sheehan J, et al：An international multicenter matched cohort analysis of incidental meningioma progression during active surveillance or after stereotactic radiosurgery：the IMPASSE study. Neuro Oncol 24：116-124, 2022

43）Morin O, et al：Integrated models incorporating radiologic and radiomic features predict meningioma grade, local failure, and overall survival. Neurooncol Adv 1：vdz011, 2019　doi:10.1093/noajnl/vdz011

44）Rogers L, et al：Intermediate-risk meningioma：initial outcomes from NRG Oncology RTOG 0539. J Neurosurg 129：35-47, 2018

45）Weber DC, et al：Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma：a phase-Ⅱ parallel non-randomized and observation study（EORTC 22042-26042）. Radiother Oncol 128：260-265, 2018

46）Goldbrunner R, et al：EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol 23：1821-1834, 2021

47）Nabors LB, et al：Central nervous system cancers, version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 18：1537-1570, 2020

48）Song D, et al：Postoperative adjuvant radiotherapy in atypical meningioma patients：a meta-analysis study. Front Oncol 11：787962, 2021　doi:10.3389/fonc.2021.787962

49）Chun SW, et al：Adjuvant radiotherapy versus observation following gross total resection for atypical meningioma：a systematic review and meta-analysis. Radiat Oncol 16：34, 2021　doi:10.1186/s13014-021-01759-9

50）Simon M, et al：Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany：impact of changes of the WHO classification. J Neurol Neurosurg Psychiatry 77：767-773, 2006

51）Chohan MO, et al：Predictors of treatment response and survival outcomes in meningioma recurrence with atypical or anaplastic histology. Neurosurgery 82：824-832, 2018

52）Pettersson-Segerlind J, et al：Long-term 25-year follow-up of surgically treated parasagittal meningiomas. World Neurosurg 76：564-571, 2011

53）Kessel KA, et al：High-precision radiotherapy for meningiomas：long-term results and patient-reported outcome（PRO）. Strahlenther Onkol 193：921-930, 2017

54）Chen WC, et al：Salvage therapy outcomes for atypical meningioma. J Neurooncol 138：425-433, 2018

55）Bagshaw HP, et al：Adjuvant radiotherapy for atypical meningiomas. J Neurosurg 126：1822-1828, 2017

56）Keric N, et al：Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas. J Neurooncol 146：347-355, 2020

57）Press RH, et al：Outcomes and patterns of failure for grade 2 meningioma treated with reduced-margin intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 88：1004-1110, 2014

58）Lee JJB, et al：Analysis of patterns of failure and appraisal of postoperative radiation field for grade Ⅱ-Ⅲ meningioma. J Neurooncol 144：333-341, 2019

59）Byun HK, et al：Adjuvant radiotherapy versus surveillance for grade 2 intracranial meningiomas：a multi-institutional propensity score-matched study. Front Oncol 12：877244, 2022　doi:10.3389/fonc.2022.877244

60）Dalle Ore CL, et al：Meningioma metastases：incidence and proposed screening paradigm. J Neurosurg 132：1447-1455, 2019

61）Surov A, et al：Distant metastases in meningioma：an underestimated problem. J Neurooncol 112：323-327, 2013

62）Rogers CL, et al：High-risk meningioma：initial outcomes from NRG Oncology/RTOG 0539. Int J Radiat Oncol Biol Phys 106：790-799, 2020

63）Kaur G, et al：Adjuvant radiotherapy for atypical and malignant meningiomas：a systematic review. Neuro Oncol 16：628-636, 2014

64）Askoxylakis V, et al：Patterns of failure after stereotactic radiotherapy of intracranial meningioma. J Neurooncol 98：367-372, 2010

65）Chan AW, et al：Dose escalation with proton radiation therapy for high-grade meningiomas. Technol Cancer Res Treat 11：607-614, 2012

66）Boskos C, et al：Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma. Int J Radiat Oncol Biol Phys 75：399-406, 2009

67）Santacroce A, et al：Long-term tumor control of benign intracranial meningiomas after radiosurgery in a series of 4565 patients. Neurosurgery 70：32-39, 2012

68）Pollock BE, et al：Single-fraction radiosurgery of benign intracranial meningiomas. Neurosurgery 71：604-613, 2012

69）Pollock BE, et al：Stereotactic radiosurgery provides equivalent tumor control to Simpson Grade 1 resection for patients with small- to medium-size meningiomas. Int J Radiat Oncol Biol Phys 55：1000-1005, 2003

70）Kaprealian T, et al：Parameters influencing local control of meningiomas treated with radiosurgery. J Neurooncol 128：357-364, 2016

71）Kondziolka D, et al：Long-term outcomes after gamma knife radiosurgery for meningiomas. Am J Clin Oncol 39：453-457, 2016

72）Ganz JC, et al：The results of Gamma Knife surgery of meningiomas, related to size of tumor and dose. Stereotact Funct Neurosurg 61 Suppl 1：23-29, 1993

73）Kuhn EN, et al：Patterns of recurrence after stereotactic radiosurgery for treatment of meningiomas. Neurosurg Focus 35：E14, 2013　doi:10.3171/2013.8.FOCUS13283

74）Islim AI, et al：Treatment outcomes of incidental intracranial meningiomas：results from the IMPACT Cohort. World Neurosurg 138：e725-e735, 2020　doi:10.1016/j.wneu.2020.03.060

75）Tuniz F, et al：Multisession cyberknife stereotactic radiosurgery of large, benign cranial base tumors：preliminary study. Neurosurgery 65：898-907, 2009

76）Bria C, et al：Fractionated stereotactic radiosurgery for the treatment of meningiomas. J Cancer Res Ther 7：52-57, 2011

77）Park HR, et al：Fractionated Gamma Knife radiosurgery as initial treatment for large skull base meningioma. Exp Neurobiol 27：245-255, 2018

78）DiBiase SJ, et al：Factors predicting local tumor control after gamma knife stereotactic radiosurgery for benign intracranial meningiomas. Int J Radiat Oncol Biol Phys 60：1515-1519, 2004

79）Sheehan JP, et al：Edema following Gamma Knife radiosurgery for parasagittal and parafalcine meningiomas. J Neurosurg 123：1287-1293, 2015

）benign meningiomas. J Neurosurg 112：951-956, 2010

81）Milano MT, et al：Radiation-induced edema after single-fraction or multifraction stereotactic radiosurgery for meningioma：a critical review. Int J Radiat Oncol Biol Phys 101：344-357, 2018

82）Choudhury A, et al：Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Nat Genet 54：649-659, 2022

83）Zhang M, et al：CyberKnife stereotactic radiosurgery for atypical and malignant meningiomas. World Neurosurg 91：574-581.e1, 2016　doi:10.1016/j.wneu.2016.04.019

84）Sun SQ, et al：Radiation therapy for residual or recurrent atypical meningioma：the effects of modality, timing, and tumor pathology on long-term outcomes. Neurosurgery 79：23-32, 2016

85）Pollock BE, et al：Stereotactic radiosurgery of World Health Organization grade Ⅱ and Ⅲ intracranial meningiomas：treatment results on the basis of a 22-year experience. Cancer 118：1048-1054, 2012

86）Barth RF, et al：Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer. Radiat Oncol 7：146, 2012　doi:10.1186/1748-717X-7-146

87）Miyatake S, et al：Survival benefit of Boron neutron capture therapy for recurrent malignant gliomas. J Neurooncol 91：199-206, 2009

88）Kawabata S, et al：Boron neutron capture therapy for newly diagnosed glioblastoma. J Radiat Res 50：51-60, 2009

89）Kaley T, et al：Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma：a RANO review. Neuro Oncol 16：829-840, 2014

90）Tom MC, et al：Beating a benchmark：boron neutron capture therapy for recurrent and refractory meningiomas. Neuro Oncol 24：99-100, 2022

91）Takai S, et al：Reactor-based boron neutron capture therapy for 44 cases of recurrent and refractory high-grade meningiomas with long-term follow-up. Neuro Oncol 24：90-98, 2022

92）Kawabata S, et al：Accelerator-based BNCT for patients with recurrent glioblastoma：a multicenter phase Ⅱ study. Neurooncol Adv 3：vdab067, 2021　doi:10.1093/noajnl/vdab067

93）Miyatake S, et al：Pseudoprogression in boron neutron capture therapy for malignant gliomas and meningiomas. Neuro Oncol 11：430-436, 2009

94）Matsumura A, et al：Initiatives toward clinical boron neutron capture therapy in Japan. Cancer Biother Radiopharm 38：201-207, 2023

95）Nassiri F, et al：A clinically applicable integrative molecular classification of meningiomas. Nature 597：119-125, 2021

96）Menke JR, et al：Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen. Acta Neuropathol 130：441-443, 2015